STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Diamyd Medical AB (www.omxgroup.com, ticker: DIAM B; www.otcqx.com, ticker DMYDY)
At today’s extra general shareholders’ meeting in Diamyd Medical AB (publ) (STO:DIAMB) it was decided, in agreement with the proposal from the Board of Directors, to authorize the Board to upon one or more occasions before the next annual shareholder’s meeting, with or without deviation from the shareholder’s preferential right, decide to issue a maximum of 91,000 B-shares (which together with the authorization from the annual shareholder’s meeting allow issuing of 991,000 B-shares) and warrants which will give the right to subscribe for a maximum of 991,000 B-shares.
